Talamanchi Balakrishna

Talamanchi Balakrishna

Auto-generated profile, based on publicly available information

Talamanchi Balakrishna

V.V. Institute of Pharmaceutical Sciences

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2018 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
BTBalakrishna T
Balakrishna T
VSVidyadhara S
Vidyadhara S
MTMurthy Tegk
Murthy Tegk
RARamu A
Ramu A
SRSasidhar Rlc
Sasidhar Rlc
Objective: The present study deals with the formulation and evaluation of fast dissolving buccal films for effective treatment option in the gastroesophageal reflux disease. Methods: Esomeprazole fast dissolving buccal films are a convenient formulation of which can be taken with or without water. In the present investigation, polyvinyl alcohol and polyvinylpyrrolidone were used as film-forming agents and polyethylene glycol 400 is taken as plasticizer. Solvent evaporation method was used for the preparation of fast dissolving buccal films. Results: The films were prepared and evaluated for film thickness, folding endurance, dispersion test, drug content, and dissolution. The in vitro dissolution studies were carried out using simulated salivary fluid (pH 6.8 phosphate buffer). Conclusion: Among all the formulations, Formulation E7 was released up to 99.6% of the drug from the film within 5 min of time which exhibits faster absorption and also shows desirable characteristics of the film. The drug-excipient interaction studies WERE carried out by Fourier-transform infrared studies, differential scanning calorimetry analysis-X-diffraction studies, and scanning electron microscopic studies and the results revealed that there were no major interactions between the drugs and excipients used for the preparation of films.

7 March 2022 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
HKHarsha Koreddi
Harsha Koreddi
VSVidyadhara Suryadevara
Vidyadhara Suryadevara
BTBalakrishna Talamanchi
Balakrishna Talamanchi
RARamu Anne
Ramu Anne
Objective: The objective of the present work is to formulate and evaluate Bosentan controlled-release microcapsules using gum karaya and polyethylene oxide as polymers, sodium alginate and calcium chloride as encapsulating material and cross-linking agent and croscarmellose sodium as superdisintegrant. Methods: Bosentan microcapsules were prepared by the ionic gelation method. The prepared microcapsules were characterized by flow properties such as angle of repose, compressibility index, particle size and encapsulation efficiency and drug release profiles. Results: The prepared microcapsules were evaluated for angle of repose, compressibility index, % drug content, encapsulation efficiency and particle size. All the flow properties were within the specified IP limits. The drug content of microcapsules prepared by ionic gelation method by varying the polymeric concentration was found in the range of 121.62±0.41 to 124.99±0.51 mg. The encapsulation efficiency of Bosentan controlled-release microcapsules was found to be in the range of 59 % to 67%. Among all the formulations prepared, formulation B14 containing equal proportions (25 mg) of gum karaya and polyethylene oxide showed about 95% of drug release over a period of 12 h and were found to be suitable for extending drug release up to 16 h. Conclusion: Bosentan controlled-release microcapsules were prepared by ionic gelation method, which is a novel formulation that is helpful in the treatment of pulmonary artery hypertension (PAH).

26 June 2024
Verified
Book Chapter
Closed access
PDF file
TBTalamanchi Balakrishna
Talamanchi Balakrishna
LALakshmana Rao Atmakuri
Lakshmana Rao Atmakuri
CPChandika Naga Veera Venkata Pravallika
Chandika Naga Veera Venkata Pravallika
CPCheruku Jigeesha Naga Durga Sai Paidi Pranitha
Cheruku Jigeesha Naga Durga Sai Paidi Pranitha
KSKollipara Baby Lakshmi Sravani
Kollipara Baby Lakshmi Sravani
AIAvisa Indira
Avisa Indira

12 February 2025 in International Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
BTBalakrishna Talamanchi
Balakrishna Talamanchi
LDLakshman Kumar Dogiparthi
Lakshman Kumar Dogiparthi
BPBala Sree Sanjeevi Pusala
Bala Sree Sanjeevi Pusala
RPRoshni Patan
Roshni Patan
VYVamsi Abhiram Yadlapalli
Vamsi Abhiram Yadlapalli
YVYasaswini Vakkalagadda
Yasaswini Vakkalagadda
Introduction The goal of this study was to develop and evaluate Bosentan transdermal patches for the treatment of Pulmonary Arterial Hypertension (PAH), which is defined as an abnormally high blood pressure in the arteries that supply blood to the lungs, in patients aged three and up. Patients with PAH may find that bosentan aids their exercise performance and slows the worsening of their symptoms.Materials and Methods Using the solvent casting method, Bosentan transdermal patches were made with karaya gum and polyethylene oxide as polymers, PEG 600 as plasticizers and propylene glycol as a permeation enhancer. Folding endurance values for the manufactured Bosentan transdermal patches ranged from 95 to 100, indicating that the patches exhibited good elasticity and flexibility. -p f.Results and Discussion The optimized formulation B-10 released 94.77% of the drug for up to 12 hr, according to the drug release trial. Studies using Fourier infrared spectroscopy and differential scanning calorimetry were carried out on the pure drug, polymers and optimised formulation B-10. The results showed that the drug and polymers did not interact with one another. There were no surface cracks or defects in the patches when SEM examination was performed on the pure drug and optimised formulation B-10.

1 December 2025 in Asian Journal of Pharmaceutics
Verified
Other
Open access
PDF file
TBT. Balakrishna
T. Balakrishna
The Asian Journal of Pharmaceutics is a peer-reviewed open-access medical journal published by Medknow Publications on behalf of the B.R. Nahata Smriti Sansthan (Memorial Trust) (Mandsaur, India). Articles address topics in pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, and clinical and hospital pharmacy.

10 July 2025
Verified
Book Chapter
Closed access
PDF file
TBTalamanchi Balakrishna
Talamanchi Balakrishna
RPRaveesha Peeriga
Raveesha Peeriga
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
KLKNV CHENCHU LAKSHMI
KNV CHENCHU LAKSHMI
MPMiriyala Preethika
Miriyala Preethika
ASAfsar Shaik
Afsar Shaik
In this chapter, we summarize recent progress in drug discovery and assess its implications for future research and development. The final section summarizes recent key findings from high-throughput screening (HTS), biomarker identification and personalized medicine. Moreover, it identifies the challenges encountered, like high costs, extended development cycles and both regulatory and commercial hurdles. Emerging trends in drug discovery, such as artificial intelligence (AI), genomic integration, and new therapeutic modalities, are explored as future prospects. By highlighting the successes, the challenges that persist, and the innovations that might alter the face of drug development, this analysis covers the full version of the progress to date. Results highlight a need for sustained interdisciplinary partnerships and continued investment in state-of-the-art technologies to overcome current constraints and progress discovery toward new, effective therapies. <!----> <!----> <!----> <!---->